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Oral infectious diseases such as dental caries, periodontal disease, endodontic infections, oral candidiasis and
peri-implantitis cause major health problems worldwide. All of these infectious diseases are associated with the
biofilm growth mode of the oral pathogens. In the past, researchers often attempted to examine the association
of single pathogens with particular dental diseases such as in the case of Streptococcus mutans acting as an
aetiological agent for dental caries and the so-called “red-complex” bacteria for periodontal disease. However,
with the recent advent of OMICS biology techniques such as genomics, transcriptomics, proteomics, it is
possible to gain new insights into the host-microbial interaction, microbial community structure and
composition in the oral cavity. The new studies on oral microbiomics can unravel the facets of the
aetiopathology of oral diseases as never seen before. This mini-review will provide an history and overview of
some of the existing DNA sequencing platforms employed to study the microbiomics of oral biofilms and the
exciting future ahead for dental research.
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Oral diseases represent a major health burden
worldwide. A wide spectrum of oral conditions is
often encountered among the human population. The
World Health Organization reported that dental
cavities are prevalent in about 60–90% of
schoolchildren and nearly 100% of adults. Severe
forms of periodontal disease, one of the most
common oral diseases in humans affects at least 15-
20% of adult population.1 Globally, about 30% of
people aged 65–74 have no natural teeth.2 Oral
cancer is one of the most prevalent forms of cancer
in the South-East Asia (SEA) region. In addition,
oral mucosal diseases, infections of the
salivary glands and oral infections with systemic
effects are common in various patient populations.
Hence, dental professionals have a significant role
to play not only in enhancing the esthetics aspects
but also in improving the oral and systemic health
of people.
A significant number of oral diseases are
infectious in nature, including dental caries,
periodontal diseases, oral candidiasis, endodontic
infections and peri-implantitis. The role of
pathogenic microorganisms in the occurrence and
25
spread of these infections has been long established.
In some anecdotal reports from ancient Mediterranean
societies and China, dental decay was attributed to
the presence “tooth worm”.3 In order to cure these
diseases, “tooth doctors” aimed to eliminate the so-
called “oral pathogen”. A clearer picture of this
“pathogen” emerged with the work of Antonie
Leeuwenhoek in 1663.4 Leeuwenhoek examined the
“white little matter’ in between his teeth using his
single-lens microscope and termed them
“animalcules”. He reported his observations to the
Royal Society of London, as “a living of animalcules
swimming nimbly than any I have ever seen…the big
short bending their body into curves in going
forward”. From another one of his experiments,
Leeuwenhoek described that, “there are more animals
living on the teeth than men in a whole kingdom, and
mainly in those people that do not clean their mouth”.
These experiments showed that “animalcules” or
bacteria have some association with the oral health
status of the individual. Subsequently, Clarke in
1924, proposed Streptococcus mutans to be the
etiological agent for dental caries.5 The pioneering
work by Socransky et al. (1988) proposed that “red-
complex” bacteria Porphyromonas gingivalis,
Treponema denticola, and Tanerella forsythia were
pathogens responsible for chronic periodontitis.6
Bacterial pathogen Aggregatibacter actinomycetem-
comitans (previously known as Actinobacillus
actinomycetemcomitans) was found to play a key role
in aggressive periodontitis (or localized juvenile
periodontitis).7 Enterococcus faecalis has been
implicated in endodontic infections.8
Until 1970s, pathogenicity models used to
describe infectious diseases were based on studies of
bacterial cultures in suspension or in the “planktonic
mode”. At that time, it was believed that bacteria
prefer to live in the planktonic lifestyle. This concept
was later changed due to the pioneering work of
William “Bill” Costerton and colleagues, who
introduced the concept of microbial biofilms.9,10
Biofilms are surface attached microbial communities.
Biofilms exhibit phenotypic traits that are different
from their “planktonic’ counterparts. Studies have
shown that at least 65-80% of all infectious diseases
are linked to the biofilm mode of microorganisms.11
The most important feature of biofilms is their higher
resistance to antimicrobials and tolerance against
immune response.12 Because of this property,
biofilms formed on body surfaces and medical
devices are very difficult to eradicate, which may
result in dire consequences to the affected patients.
Biofilm formation of microbial species
generally follow a similar pattern, although there
may be some variations among different species
and strains.13-14 Microbes in free-floating or
“planktonic” mode, when in close proximity to
biotic or abiotic surfaces, encounter attractive as
well as repulsive forces between the organism and
the surface. These include electrostatic and
hydrophobic interactions, steric hindrance, van der
Waals forces, temperature, and hydrodynamic
forces. Apart from the properties of the microbial
cell wall, surface properties such as surface charge,
roughness, hydrophobicity, configuration topo-
graphy, and surface free energy also determine the
attachment of microbes to a particular surface.
Following surface attachment, the adhered cells
multiply and form micro-colonies. In parallel, the
attached cells also secrete extracellular polymeric
substances (EPS) which serve to form a protective
matrix around the cells. With time, the biofilm
matures resulting in an organized three-dimensional
structure.14 In the final step of this sequence of
events, some of the attached cells may disperse
from the biofilms to colonize new surfaces (Figure
1). These dispersed cells are known to be different
from the “original planktonic” organisms. For
instance, dispersed cells are more resistant to
antimicrobials than planktonic cells.
The establishment of biofilm lifestyle makes
the microorganisms highly resistant to anti-
microbials. For example, biofilm infections of
Gram-positive or Gram-negative microorganisms
may not be eradicated by commonly used
antibiotics such as penicillin or metronidazole,
which work well for their planktonic counterparts.15
Similarly, commonly used mouthwashes containing
0.2 % chlorhexidine are not active against biofilms
of oral pathogens.16 Higher drug resistance of the
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Human body surfaces such as oral cavity,
respiratory tract, gastrointestinal tract, genital organs
as well as conjunctiva are exposed to external
environments and are invariably colonized by various
microbial populations, creating unique niches.17 An
interesting feature of the oral cavity is that it provides
both hard and soft surfaces for microbial colonization.
Therefore, the microbial communities formed on tooth
surfaces or dental plaque are different from the ones
formed on oral mucosal surfaces. Saliva contains
bacteria from various oral niches as well external
transient microorganisms.
Dental plaque is an archetypical biofilm.18
Assessment of the population dynamics of dental
plaque or other oral biofilms may be useful in the
diagnosis and evaluation of various oral conditions.
However, a complete analysis of all the micro-
organisms in biofilms is not possible using culture-
dependent techniques. Before the advent of DNA-
based sequencing techniques, the composition of
dental plaque was estimated to be around 200 species.
In order to obtain a comprehensive picture of the
dental plaque composition, National Institute of
Health (NIH) initiated the Human Microbiome
Project (HMP) using high-throughput techno-
logies such as 16S rDNA sequencing.19
The use of high-throughput sequencing
techniques has made it feasible to study the whole
microbial community in both health and disease.20
There are many aspects of diseases that
researchers would like to query, such as the
etiology, diagnostic and prognostic biomarkers as
well as the therapeutic modalities. In the past,
most of the oral diseases related studies were
hypothesis-driven. Though, these studies have
contributed to findings of etiological agents as
well as therapeutic modalities, the realization of
the complexity of biological systems makes it
imperative to look at the big picture. This
necessity of understanding how a system works
propelled efforts in the development of omics
biology. The term omics encompasses various
Figure 1. Sequential events taken place during microbial biofilm formation
(Reproduced with permission from Seneviratne et al., 2008).
biofilm mode of growth has been attributed to the
following factors: i) altered physiological status of
the biofilm cells, ii) protective effect of EPS, iii)
presence of a highly drug tolerant subpopulation
called persisters, iv) higher anti-oxidative capacities
of biofilm cells, and v) differential gene expression
profiles of biofilm cells.12
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fields such as genomics, proteomics, transcriptomics,
metabolomics, and epigenomics, etc. The initial phase
of omics studies is generally hypothesis-free. Hence,
the idea behind any omics study is to obtain a complete
view of the feature under examination. The holistic
evaluation of microbial communities and composition
has initiated the field of microbiomics.
One of the commonly used techniques in oral
microbiomics is to study the microbial composition
and community structure through DNA sequencing
of dental plaque or saliva samples of the study
population. DNA sequencing involves the precise
determination of the order of the four nucleotides,
namely, adenine, guanine, cytosine, and thymine——
occurring in a strand of DNA. Gilbert and Sanger
pioneered the development of the first DNA
sequencing methods.21,22 Consequently, the first whole
genome sequence of bacteriophage φX174 was
obtained using Sanger sequencing in 197723, followed
by the sequencing of Epestein-Barr virus in 1984, and
Saccharomyces cerevisiae in 1996.24 In more recent
times, shotgun sequencing methods are preferred over
the traditional sequencing methods due to their
improved speed and accuracy. The first draft of the
human genome was released in 2001 by Human
Genome Organization (HUGO) using shotgun
sequencing methods.25,26 Next generation sequencing
(NGS) is the latest in a series of advanced DNA
sequencing technologies that provides a much higher
throughput and sequencing depth than that of the
conventional methods. Pyrosequencing is one of the
NGS techniques that eliminates the need for cloning
and sequencing by amplifying a single DNA
molecule.27,28 Roche 454 pyrosequencer can generate
up to one million copies in a run with read lengths of
500 to 600 bases.29 The resultant sampling depth
allows for the detection of even rare and low
abundance bacterial taxa.30
Pyrosequencing methods are able to provide a
holistic view of the diversity and composition of oral
biofilms revealing the remarkable diversity of oral
microbiome.31,32. A study of saliva and supragingival
plaque samples employing pyrosequencing methods
estimated the presence of approximately 19,000
phylotypes in human oral microflora, a considerably
higher number than in previous reports.31 However, in
pyrosequencing platforms such as Roche 454, the high
cost of reagents remains a drawback.33 A
combination of 454 and Illumina sequencing
platforms has also been used in a recent study to
obtain the first gene catalog of dental plaque
microbiome.34 Other sequencing platforms such
as Illumina GAIIx and HiSeq 2000 instruments
have helped in identifying more than 175 bacterial
species at a greater than 90% accuracy rate in
human saliva.35 The SOLiD system (Small
Oligonucleotide Ligation and Detection System)
based on sequencing by ligation of dye-labeled
oligonucleotidesgenerates up to 4 gigabytes of
sequence, but with short read lengths of only
35 nucleotides.27
In contrast, the Pacific Biosystem system
allows for very long read lengths of greater
than1,000 nucleotides, but with the setback of the
highest error rates (ca. 17%) among all the NGS
platforms.36 The choice of an appropriate
sequencing system may vary from sample to
sample. Therefore, for different sample types, an
optimal balance of factors such as cost, efficiency,
and accuracy may help in deciding upon a suitable
platform. However, it is also to be kept in mind
that 16S rDNA sequencing can provide only the
taxonomic details of the sample under
investigation, without providing functional
characterization.37
The high throughput studies of dental plaque
and other oral biofilms have revealed that there is a
remarkable diversity observed in the oral
microbiome.38 In addition, oral microbiota may
also be linked with the systemic diseases such as
respiratory tract infections, gastrointestinal
diseases, cardiovascular disease, and adverse
gestational outcomes makes.39 However, defining
a health or disease-associated core microbiome for
oral diseases is still a very difficult task. Human
oral microbiome studies have suggested that due to
subtle variations, there is a unique microbiome
fingerprint for every individual.40 In addition,
there may be variations in the formation of dental
plaque biofilms. A recent study demonstrated
differences can exist in the ultra-structure and
morphology of the dental plaque biofilms of
“slow” and “fast” plaque formers.41 Future oral
microbiomics studies should therefore be directed
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towards addressing these differences. The detection
limit and accuracy of NGS sequencing supersedes
the power of traditional culture-dependent
techniques. Therefore, future oral microbiomics
studies will certainly expand our knowledge on the
etiopoathology of dental infectious diseases.
The advent of microbiomics has opened up a
new avenue for unravelling the etiopathology of
oral biofilm-associated diseases. Although these
novel omics techniques have not yet been
adequately employed for the above-mentioned
purpose at present, growing interest in the field is
expected to drive dental research in the
future. As Martha Somerman, director of the
National Institute of Dental and Craniofacial
Research (NIDCR) stated in 2013, omics biology
will be instrumental in devising oral health
informatics profiles of the individual in future.42
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